Perspectiva general

The 2024 DIA India Annual Meeting is an occasion for industry professionals, regulatory authorities, and decision-makers to convene in one place and discuss the current healthcare landscape in India. This year, we are excited to introduce a new feature with three specialized tracks focusing on medical devices, pharmacovigilance, and clinical topics. These tracks will provide in-depth exploration and discussion on key areas of interest within each field, allowing attendees to gain valuable insights and network with experts in their respective domains.

Additionally, the meeting will continue to serve as a platform for decision-makers to align, share challenges and opportunities, and hear from experts about their vision for the future. Expect thought-provoking discussions on current issues like AI, an exchange of innovative ideas between diverse stakeholders, and the potential for strategic collaborations.

Temas destacados

Clinical: a focus on the role of technology and AI in healthcare.
Medical Devices: Expect a discussion on development, clinical data, and the challenges and opportunities from upcoming regulations.
Pharmacovigilance: Exploration of key regulatory, clinical, and vigilance strategies for medical devices, risk mitigation strategies of chemotherapeutic agents, and more.
Hot Topics/Current Issues: From acquisitions and mergers to AI in PV, clinical development, and regulatory sciences.

Objetivos de aprendizaje

Attendees of the 2024 DIA India Annual Meeting can expect to:

Gain insights into the changing landscape of the healthcare industry in India.
Understand the challenges and opportunities presented by upcoming regulations in the field of medical devices.
Discuss challenges and opportunities in patient engagement, regulatory affairs, and pharmacology, among others.
Engage in insightful dialogues with industry professionals and decision-makers.
Network with key stakeholders and potential collaborators in healthcare.

Comité del programa

Moin Don Founder and CEO, PVCON Consulting, Lead: South Asia Chapter (ISoP),
International Society of Pharmacovigilance (ISoP), India
Ashish Indani Senior Manager – Clinical Affairs Neurovascular
Stryker Global Technology Center, India
Fahd Khan Head Business Development - APAC
Emmes, India
Prashant Joshi, RPh Executive Director - Drug Safety
Fortrea, India
Ritu Jaswal Vice President - Pharmacovigilance Operations
Parexel, India
Shadab Makhdoomi Vice President
Accenture Life Sciences, India
Sonica Sachdeva Batra, MD Associate Vice President Enterprise Medical Head- Regulatory Solutions
Indegene, India
J Vijay Venkatraman, MD, MBA Managing Director and CEO
Oviya MedSafe, India
Vijay Bhargav Vice President, Lifecycle Safety
IQVIA, India
Swapnali Raut Director, Clinical Operations, Global Monitoring and Site Engagement (GMASE)
Global Clinical Operations Development – R&D, GSK, India
Pramod Kashid CEO
Expecto Health Science, Singapore
Manjusha Rajarshi Founder Regulus Healthcare
Partner at roots-simplified Research and Consulting LLP, India
Manish Paliwal Director, Regulatory Affairs
Pfizer, Inc., India
Omprakash Sadhwani Ex-Joint Commissioner (HQ) and Drugs Controller
Maharashtra Food and Drug Administration, India
Priyadarshini Arambam General Manager Clinical Research Operations, Academic and Research Department
Batra Hospital and Medical Research Center, India
Susan Korah Delivery Head- Healthcare and MedTech,
Tata Consultancy Services, India

¿Tiene una cuenta?

DIA India Annual Meeting 2024

Perspectiva general

Temas destacados

¿Quiénes deben asistir?

Objetivos de aprendizaje

Comité del programa

Be informed and stay engaged.